A joint research initiative between the University of Kentucky and the University of Louisville.

Research Funding Opportunities: ____________________________________________________

Call for Proposals through UK Markey Cancer Center:

 

Kentucky Lung Cancer Research Program:

Investigator-Initiated Research Program Overview

 

In 2000, the Kentucky General Assembly established the Lung Cancer Research Fund. This 20-year initiative serves as the incentive for collaborative efforts of the University of Kentucky and the University of Louisville to become nationally recognized as leaders in lung cancer epidemiology, diagnosis and treatment.  A Governance Board, appointed by the Governor, administers the Kentucky Lung Cancer Research (KLCR) Program.  The Board allocates research funds to the universities to accelerate the science associated with reducing morbidity and mortality from lung cancer. 

KLCR Program provides grant support for:

  • New researchers who demonstrate promise and who have a supportive environment for their work;
  • Established and productive researchers who propose to apply their prior work to lung cancer research;
  • Researchers with novel ideas who wish to test their ideas and develop pilot data for seeking larger awards from the National Institutes of Health (NIH) and other funding sources; and
  • Collaborative research between investigators at the University of Kentucky and the University of Louisville.

Guidelines and Application

Please see the attached documents for details:

KLCR Cycle 11 Grant Application Guidelines

KLCR Cycle 11 Grant Application

Briefly, Cycle 11 proposals must satisfy each of the following criteria:

1) Each proposal must cover a lung cancer or tobacco use research topic that fits into one of the four research programs of the Markey Cancer Center. The four programs are:

Cancer Cell Biology and Signaling
Cancer Prevention and Control
Experimental Therapeutics
Redox Injury and Repair

2) Each proposal must be the result of collaboration between at least one basic or population science researcher and one clinical researcher.

3) Each proposal must clearly articulate plans to utilize at least two of the Markey Cancer Center shared resources listed below. Letters of Intent and the grant application must include a letter of support from the directors of the shared resources to be used.

Biospecimen
Biostatistics
Flow Cytometry
Informatics
Redox Chemistry and Biology

4) Each proposal must articulate plans to use human subjects and/or human tissue by the end of the two year funding period.

Applications that were not preceded by a Letter of Intent (including shared resource letters of support), those not meeting the four criteria described above and/or those that are incomplete will be administratively withdrawn without review.  

Timeline
Release Date:  November 7, 2011
Letter of Intent Date:  December 14, 2011
Application Due Date: January 6, 2012
Peer Review Dates:  January 18 – March 1, 2012
Governance Board Review:  March 14 – April 30, 2012
Start Date:  May 1, 2012
End Date:  April 30, 2014

Questions about this opportunity should be directed to Nathan Vanderford, PhD, at nathan.vanderford@uky.edu.

___________________________________________________________________

U.S. Department of Health and Human Services:

http://grants.nih.gov/grants/oer.htm

 

American Cancer Society:

http://www.cancer.org/Research/ResearchProgramsFunding/indexm

 

 

 

 

 

 

 
© 2007 Kentucky Lung Cancer Research Program